Jerneja Farkaš

1.2k total citations
46 papers, 850 citations indexed

About

Jerneja Farkaš is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, Jerneja Farkaš has authored 46 papers receiving a total of 850 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 12 papers in Pulmonary and Respiratory Medicine and 9 papers in Physiology. Recurrent topics in Jerneja Farkaš's work include Heart Failure Treatment and Management (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Cardiovascular Function and Risk Factors (7 papers). Jerneja Farkaš is often cited by papers focused on Heart Failure Treatment and Management (15 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (10 papers) and Cardiovascular Function and Risk Factors (7 papers). Jerneja Farkaš collaborates with scholars based in Slovenia, Germany and Serbia. Jerneja Farkaš's co-authors include Mitja Lainščak, Stephan von Haehling, Mitja Košnik, Jan Mårtensson, Stefan D. Anker, Tiny Jaarsma, Anna Strömberg, Lijana Zaletel‐Kragelj, John E. Morley and Kamyar Kalantar‐Zadeh and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and CHEST Journal.

In The Last Decade

Jerneja Farkaš

41 papers receiving 841 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jerneja Farkaš Slovenia 16 321 252 170 115 109 46 850
Katarina Halling Sweden 16 302 0.9× 168 0.7× 154 0.9× 54 0.5× 86 0.8× 39 1.8k
Wern Ee Tang Singapore 20 269 0.8× 219 0.9× 52 0.3× 76 0.7× 202 1.9× 87 1.1k
Peter Hayes Ireland 12 185 0.6× 60 0.2× 71 0.4× 78 0.7× 169 1.6× 36 619
Lufei Young United States 17 281 0.9× 73 0.3× 47 0.3× 197 1.7× 105 1.0× 70 879
Trent McLaughlin United States 17 80 0.2× 273 1.1× 231 1.4× 138 1.2× 92 0.8× 50 994
Ali Yazdanyar United States 9 242 0.8× 109 0.4× 72 0.4× 52 0.5× 122 1.1× 39 705
Pearl Lee United States 13 83 0.3× 131 0.5× 36 0.2× 108 0.9× 137 1.3× 33 838
Andreas Wielgosz Canada 15 432 1.3× 70 0.3× 91 0.5× 104 0.9× 128 1.2× 35 886
Bogdan Wyrzykowski Poland 18 365 1.1× 126 0.5× 71 0.4× 128 1.1× 119 1.1× 71 992
Javier Cid‐Ruzafa United States 10 69 0.2× 203 0.8× 380 2.2× 72 0.6× 164 1.5× 20 1.1k

Countries citing papers authored by Jerneja Farkaš

Since Specialization
Citations

This map shows the geographic impact of Jerneja Farkaš's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jerneja Farkaš with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jerneja Farkaš more than expected).

Fields of papers citing papers by Jerneja Farkaš

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jerneja Farkaš. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jerneja Farkaš. The network helps show where Jerneja Farkaš may publish in the future.

Co-authorship network of co-authors of Jerneja Farkaš

This figure shows the co-authorship network connecting the top 25 collaborators of Jerneja Farkaš. A scholar is included among the top collaborators of Jerneja Farkaš based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jerneja Farkaš. Jerneja Farkaš is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rosano, Giuseppe & Jerneja Farkaš. (2023). Evolving targets for heart failure: the journey so far. SHILAP Revista de lepidopterología. 1(1). 5 indexed citations
2.
Rosano, Giuseppe & Jerneja Farkaš. (2023). Evolving targets for heart failure: the journey so far. 1(1).
3.
Rosano, Giuseppe & Jerneja Farkaš. (2023). Evolving targets for heart failure: the journey so far. 1(1). 1 indexed citations
4.
Farkaš, Jerneja, et al.. (2022). Zaznavanje zdravja in družbeni razredi v Sloveniji: ali obstaja povezava?. 1(1). 67–74.
5.
Farkaš, Jerneja, et al.. (2020). Beliefs and practices regarding electronic cigarettes insmoking cessation among healthcare professionals in Slovenia. Tobacco Prevention & Cessation. 6(January). 3–3. 4 indexed citations
6.
Loncar, Goran, et al.. (2019). Micronutrient Depletion in Heart Failure: Common, Clinically Relevant and Treatable. International Journal of Molecular Sciences. 20(22). 5627–5627. 26 indexed citations
7.
Lainščak, Mitja, et al.. (2019). Heart Failure Prevalence in the General Population: SOBOTA-HF Study Rationale and Design. ESC Heart Failure. 6(5). 1077–1084. 7 indexed citations
8.
Eržen, Ivan, et al.. (2019). Regional Differences in Heart Failure Hospitalizations, Mortality, and Readmissions in Slovenia 2004–2012. ESC Heart Failure. 6(5). 965–974. 5 indexed citations
9.
Chiou, Shu-Ti, et al.. (2018). A WHO-HPH operational program versus usual routines for implementing clinical health promotion: an RCT in health promoting hospitals (HPH). Implementation Science. 13(1). 153–153. 6 indexed citations
10.
Farkaš, Jerneja, et al.. (2016). National Trends in Heart Failure Hospitalization Rates in Slovenia 2004–2012. European Journal of Heart Failure. 18(11). 1321–1328. 48 indexed citations
11.
Lainščak, Mitja, et al.. (2016). Mortality and readmissions in heart failure: an analysis of 36,824 elderly patients from the Slovenian national hospitalization database. Wiener klinische Wochenschrift. 128(S7). 512–518. 10 indexed citations
12.
Loncar, Goran, et al.. (2016). Heart failure management in the elderly – a public health challenge. Wiener klinische Wochenschrift. 128(S7). 466–473. 8 indexed citations
13.
Stanković, Ivan, Radosav Vidaković, Jerneja Farkaš, et al.. (2015). Prognostic implications of heart failure with preserved ejection fraction in patients with an exacerbation of chronic obstructive pulmonary disease. Internal and Emergency Medicine. 11(4). 519–527. 17 indexed citations
14.
Farkaš, Jerneja & Mitja Lainščak. (2014). Assessment of public awareness on chronic obstructive pulmonary disease in Slovenia. European Respiratory Journal. 44(Suppl 58). P1464–P1464. 2 indexed citations
15.
Farkaš, Jerneja, Stephan von Haehling, Kamyar Kalantar‐Zadeh, et al.. (2013). Cachexia as a major public health problem: frequent, costly, and deadly. Journal of Cachexia Sarcopenia and Muscle. 4(3). 173–178. 121 indexed citations
16.
Lainščak, Mitja, et al.. (2013). Discharge Coordinator Intervention Prevents Hospitalizations in Patients With COPD: A Randomized Controlled Trial. Journal of the American Medical Directors Association. 14(6). 450.e1–450.e6. 49 indexed citations
17.
Farkaš, Jerneja, Mitja Košnik, Matjaž Fležar, Stanislav Šuškovič, & Mitja Lainščak. (2010). Self-Rated Health Predicts Acute Exacerbations and Hospitalizations in Patients With COPD. CHEST Journal. 138(2). 323–330. 34 indexed citations
18.
Farkaš, Jerneja, Samantha Nabb, Lijana Zaletel‐Kragelj, John G.F. Cleland, & Mitja Lainščak. (2009). Self-Rated Health and Mortality in Patients with Chronic Heart Failure. European Journal of Heart Failure. 11(5). 518–524. 50 indexed citations
19.
Farkaš, Jerneja, Mitja Košnik, Lijana Zaletel‐Kragelj, et al.. (2009). Distribution of self-rated health and association with clinical parameters in patients with chronic obstructive pulmonary disease. Wiener klinische Wochenschrift. 121(9-10). 297–302. 13 indexed citations
20.
Farkaš, Jerneja. (1984). Simuliosis. Analysis of dermatological manifestations following blackfly (Simuliidae) bites as observed in the years 1981-1983 in Bratislava (Czechoslovakia).. PubMed. 32(5). 171–3. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katarina Halling Breakdown of academic impact, for papers by Wern Ee Tang Breakdown of academic impact, for papers by Peter Hayes Breakdown of academic impact, for papers by Lufei Young Breakdown of academic impact, for papers by Trent McLaughlin Breakdown of academic impact, for papers by Ali Yazdanyar Breakdown of academic impact, for papers by Pearl Lee Breakdown of academic impact, for papers by Andreas Wielgosz Breakdown of academic impact, for papers by Bogdan Wyrzykowski Breakdown of academic impact, for papers by Javier Cid‐Ruzafa
Rankless by CCL
2026